EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RARα1 control of mammary gland ductal morphogenesis and wnt1-tumorigenesis



RARα1 control of mammary gland ductal morphogenesis and wnt1-tumorigenesis



Breast Cancer Research 12(5): R79-R79



Retinoic acid signaling pathways are disabled in human breast cancer suggesting a controlling role in normal mammary growth that might be lost in tumorigenesis. We tested a single receptor isotype, RARα1, for its role in mouse mammary gland morphogenesis and MMTV-wnt1-induced oncogenesis. The role of RARα1 in mammary morphogenesis was tested in RARα1-knockout (KO) mice and in mammary tumorigenesis in bi-genic (RARα1/KO crossed with MMTV-wnt1) mice. We used whole mounts analysis, stem cells/progenitor quantification, mammary gland repopulation, Q-PCR, test of tumor-free survival, tumor fragments and cell transplantation. In 2 genetic backgrounds (129/Bl-6 and FVB) the neo-natal RARα1/KO-mammary epithelial tree was 2-fold larger and the pubertal tree had 2-fold more branch points and 5-fold more mature end buds, a phenotype that was predominantly epithelial cell autonomous. The stem/progenitor compartment of the RARα1/KO mammary, defined as CD24(low)/ALDH(high activity) was increased by a median 1.7 fold, but the mammary stem cell (MaSC)-containing compartment, (CD24(low)/CD29(high)), was larger (~1.5 fold) in the wt-glands, and the mammary repopulating ability of the wt-gland epithelium was ~2-fold greater. In MMTV-wnt1 transgenic glands the progenitor (CD24(low)/ALDH(high activity)) content was 2.6-fold greater than in the wt and was further increased in the RARα1/KO-wnt1 glands. The tumor-free survival of RARα1/KO-wnt1 mice was significantly (p=0.0002, Kaplan Meier) longer, the in vivo growth of RARα1/KO-wnt1 transplanted tumor fragments was significantly (p=0.01) slower and RARα1/KO-wnt1 tumors cell suspension produced tumors after much longer latency. In vitamin A-replete mice, RARα1 is required to maintain normal mammary morphogenesis, but paradoxically, also efficient tumorigenesis. While its loss increases the density of the mammary epithelial tree and the content of luminal mammary progenitors, it appears to reduce the size of the MaSC-containing compartment, the mammary repopulating activity, and to delay significantly the MMTV-wnt1-mammary tumorigenesis. Whether the delay in tumorigenesis is solely due to a reduction in wnt1 target cells or due to additional mechanisms remains to be determined. These results reveal the intricate nature of the retinoid signaling pathways in mammary development and carcinogenesis and suggest that a better understanding will be needed before retinoids can join the armament of effective anti- breast cancer therapies.

(PDF emailed within 0-6 h: $19.90)

Accession: 055333359

Download citation: RISBibTeXText

PMID: 20923554

DOI: 10.1186/bcr2724



Related references

The Wnt signaling receptor Lrp5 is required for mammary ductal stem cell activity and Wnt1-induced tumorigenesis. Journal of Biological Chemistry 281(46): 35081-7, 2006

Extracellular matrix control of mammary gland morphogenesis and tumorigenesis: insights from imaging. Histochemistry and Cell Biology 130(6): 1105-1118, 2008

Transgenic mice overexpressing tgf alpha exhibit impeded ductal morphogenesis in the mammary gland and ductal metaplasia in the pancreas. Journal of Cellular Biochemistry Supplement (14 PART E): 79, 1990

Pttg1/securin is required for the branching morphogenesis of the mammary gland and suppresses mammary tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America 111(3): 1008-1013, 2014

P190-B, an unconventional RhoGTPase activating protein, in cell invasion during ductal morphogenesis and mammary tumorigenesis. Breast Cancer Research & Treatment 69(3): 313, October, 2001

Transforming growth factor-beta regulator SnoN modulates mammary gland branching morphogenesis, postlactational involution, and mammary tumorigenesis. Cancer Research 70(10): 4204-4213, 2010

Milk protein expression and ductal morphogenesis in the mammary gland in vitro: hormone-dependent and -independent phases of adipocyte-mammary epithelial cell interaction. Developmental Biology 120(1): 245-258, 1987

ErbB2 is required for ductal morphogenesis of the mammary gland. Proceedings of the National Academy of Sciences of the United States of America 101(49): 17138-17143, 2004

ErbB3 is required for ductal morphogenesis in the mouse mammary gland. Breast Cancer Research 10(6): R96-R96, 2009

Inhibition of ductal morphogenesis in the mammary gland of WAP -fgf4 transgenic mice. Anatomy and Embryology 206(6): 471-478, 2003

Key stages in mammary gland development: the cues that regulate ductal branching morphogenesis. Breast Cancer Research 8(1): 201-201, 2006

Ptch1 is required locally for mammary gland morphogenesis and systemically for ductal elongation. Development 136(9): 1423-1432, 2009

Induction of ductal morphogenesis and lobular hyperplasia by amphiregulin in the mouse mammary gland. Cell Growth & Differentiation 7(12): 1769-1781, 1996

Apoptosis in the terminal endbud of the murine mammary gland: a mechanism of ductal morphogenesis. Development 122(12): 4013-4022, 1996

Genetic control of ductal morphology, estrogen-induced ductal growth, and gene expression in female mouse mammary gland. Endocrinology 155(8): 3025-3035, 2014